Updated HACOR Score Calculator – NIV Failure Risk Assessment

Clinical calculation support · Verify results before clinical use

Updated HACOR Assessment

Estimate the risk of noninvasive ventilation (NIV) failure in acute hypoxemic respiratory failure.

0–25+ POINTS

Enter the patient's pre-NIV clinical profile once, then record bedside parameters at each assessment time. The baseline modifiers remain constant across serial assessments.

Baseline clinical profile (before NIV)

Use the total SOFA score calculated before NIV initiation.
Select all diagnoses or conditions that apply.
Clinical population: The 2022 updated model excluded acute hypercapnic respiratory failure (including COPD exacerbation), post-extubation NIV, emergency intubation, and patients younger than 16 years. Its evidence should not be extrapolated automatically to these populations.

Serial NIV assessment

Record heart rate, arterial pH, GCS, oxygenation and respiratory rate.

HACOR × 4

Before NIV initiation

Baseline HACOR measurement.

—Updated score
Enter the baseline SOFA score, baseline modifiers, and at least one complete assessment to calculate the Updated HACOR score.
Scores update automatically when valid inputs are entered. Incomplete assessment time points are not scored.

About the Updated HACOR Score

The Updated HACOR score combines the original five-variable HACOR score with six pre-NIV clinical variables to improve prediction of NIV failure in adults with acute hypoxemic respiratory failure.

Original HACOR components

VariableValuePoints
Heart rate≤120 / ≥121 beats/min0 / 1
Arterial pH≥7.35; 7.30–7.34; 7.25–7.29; <7.250; 2; 3; 4
GCS15; 13–14; 11–12; ≤100; 2; 5; 10
PaO₂/FiO₂ (mmHg)≥201; 176–200; 151–175; 126–150; 101–125; ≤1000; 2; 3; 4; 5; 6
Respiratory rate≤30; 31–35; 36–40; 41–45; ≥46 /min0; 1; 2; 3; 4

Updated baseline modifiers

Baseline variablePoints
SOFA score0.5 × SOFA
Pneumonia+2.5
Cardiogenic pulmonary edema−4
Pulmonary ARDS+3
Immunosuppression+1.5
Septic shock+2.5

Interpretation after 1–2 hours of NIV

Updated HACORRisk categoryNIV failure rate
≤7Low12.4%
7.5–10.5Moderate38.2%
11–14High67.1%
>14Very high83.7%

Risk categories and observed failure rates above were reported for the 1–2-hour assessment cohort. They should not be interpreted as an individualized calibrated probability for every patient or every time point.

References

Duan J, Han X, Bai L, et al.Assessment of heart rate, acidosis, consciousness, oxygenation, and respiratory rate to predict noninvasive ventilation failure in hypoxemic patients. Intensive Care Med. 2017;43:192–199. DOI: 10.1007/s00134-016-4601-3.
Duan J, Chen L, Liu X, et al.An updated HACOR score for predicting the failure of noninvasive ventilation: a multicenter prospective observational study. Crit Care. 2022;26:196. DOI: 10.1186/s13054-022-04060-7.
Shekhar S, Ramu R, Senthilnathan M, Sekar D.Validation of the updated HACOR Score for predicting non-invasive ventilation failure in acute hypoxemic respiratory failure. Indian J Med Res. 2026. Epub ahead of print October 12, 2026. DOI: 10.25259/IJMR_1214_2026. Prospective external validation (n=50); HACOR-U AUROC 0.764 at 1–2 h. The small sample limits certainty.
American Thoracic Society.Noninvasive respiratory support for adult patients with acute respiratory failure: an official American Thoracic Society Clinical Practice Guideline. 2025. Official guideline.

Important limitations

  • The updated score was developed and externally validated in hypoxemic respiratory failure; the derivation study excluded hypercapnic respiratory failure, COPD exacerbation, post-extubation NIV and emergency intubation.
  • The score supports risk assessment; it does not replace clinical assessment, airway evaluation, hemodynamic monitoring or timely escalation.
  • Risk bands are presented as published cohort strata, not as a stand-alone intubation threshold.
Clinical disclaimer: The Updated HACOR score is an adjunctive prognostic tool for NIV failure risk in acute hypoxemic respiratory failure. It must not be used as the sole basis for intubation or continuation of NIV. Immediate clinical deterioration, respiratory or cardiac arrest, inability to protect the airway, refractory hypoxemia, worsening shock or other urgent indications require prompt clinical action regardless of the calculated score. Use continuous clinical reassessment and ensure timely access to invasive ventilation when indicated.